Back to search results

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Abroad (travel likely)RecruitingPHASE1

Conditions

Mitochondrial Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Columbia University Irving Medical Center, New York, New York, United States

    Contact: Study coordinator (Kris Engelstad, MS, CGC) · ke4@cumc.columbia.edu · 212-342-5767
    Contact: Principal Investigator (Michio Hirano, MD)
Study leads

  • Michio Hirano, MD

    Principal Investigator

    Columbia University

View source on ClinicalTrials.gov(opens in a new tab)